7/25/2018 12:49:38 PM - Violated its 50 DMA line with today's big volume-driven loss. Reported earnings +16% on +14% sales revenues for the Jun '18 quarter. Prior quarterly earnings comparisons were not strong and steady above the +25% minimum guideline (C criteria) and fundamental concerns remain. Annual earnings (A criteria) history has been slow and steady but not a match with the fact-based investment system's guidelines.

4/26/2018 1:00:40 PM - Rebounded above its 50 DMA line with volume-driven gains this week. Reported earnings +38% on +15% sales revenues for the Mar '18 quarter and recent quarterly comparisons have shown encouraging acceleration in sales and earnings. Prior quarterly earnings comparisons were below the +25% minimum guideline (C criteria). Fundamental concerns remain and it was noted with caution in prior mid-day reports - "Sub par quarterly sales revenues growth and its up and down annual earnings (A criteria) are not a match with the fact-based investment system's guidelines."

4/19/2018 1:06:57 PM - Slumping below its 50 DMA line. Reported earnings +24% on +10% sales revenues for the Dec '17 quarter, and prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). Fundamental concerns remain and it was noted with caution in prior mid-day reports - "Sub par quarterly sales revenues growth and its up and down annual earnings (A criteria) are not a match with the fact-based investment system's guidelines."

3/1/2017 1:03:35 PM - Reported earnings +19% on +14% sales revenues for the Dec '16 quarter, and fundamental concerns remain. Gapped down on the prior session, but finding support near its 50 DMA line. Noted with caution in the 12/15/16 mid-day report - "Reported earnings +51% on +14% sales revenues for the Sep '16 quarter, Sub par quarterly sales revenues growth and its up and down annual earnings (A criteria) are not a match with the fact-based investment system's guidelines."

2/28/2017 12:43:32 PM - Reported earnings +19% on +14% sales revenues for the Dec '16 quarter, and fundamental concerns remain. Gapped down today, retreating below its 50 DMA line. Noted with caution in the 12/15/16 mid-day report - "Reported earnings +51% on +14% sales revenues for the Sep '16 quarter, Sub par quarterly sales revenues growth and its up and down annual earnings (A criteria) are not a match with the fact-based investment system's guidelines."

2/2/2017 12:27:47 PM - Reported earnings +19% on +14% sales revenues for the Dec '16 quarter and fundamental concerns remain. Hitting new highs with today's 2nd consecutive volume-driven gain. Found support near its 50 DMA line during its orderly consolidation since noted with caution in the 12/15/16 mid-day report - "Reported earnings +51% on +14% sales revenues for the Sep '16 quarter, Sub par quarterly sales revenues growth and its up and down annual earnings (A criteria) are not a match with the fact-based investment system's guidelines."

2/1/2017 12:38:52 PM - Reported earnings +19% on +14% sales revenues for the Dec '16 quarter and fundamental concerns remain. Found support near its 50 DMA line during its orderly consolidation since noted with caution in the 12/15/16 mid-day report - "Reported earnings +51% on +14% sales revenues for the Sep '16 quarter, Sub par quarterly sales revenues growth and its up and down annual earnings (A criteria) are not a match with the fact-based investment system's guidelines."

1/24/2017 12:43:24 PM - Found support near its 50 DMA line during its orderly consolidation since last noted with caution in the 12/15/16 mid-day report - "Reported earnings +51% on +14% sales revenues for the Sep '16 quarter, Sub par quarterly sales revenues growth and its up and down annual earnings (A criteria) are not a match with the fact-based investment system's guidelines."

12/15/2016 12:29:58 PM - Reported earnings +51% on +14% sales revenues for the Sep '16 quarter, Sub par quarterly sales revenues growth and its up and down annual earnings (A criteria) are not a match with the fact-based investment system's guidelines.